Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

B8F.L (B8F) Regulatory News

12
Date Source Headline
30th Mar 2015 7:00 am RNS Notice of Results
25th Mar 2015 7:00 am RNS Sales and Marketing of Ameluz® in Spain
26th Jan 2015 7:00 am RNS Ameluz Belgium launch and Clinical Trials Update
22nd Jan 2015 8:00 am RNS Change of Adviser
5th Dec 2014 9:00 am RNS Belixos(R) Gel addition to derma product range
26th Nov 2014 7:00 am RNS Ameluz International Approval Procedure
13th Nov 2014 7:00 am RNS 3rd Quarter Results - 9mnths to 30 Sept 2014
7th Nov 2014 8:20 am RNS Ameluz distribution for Spanish market
27th Oct 2014 10:00 am RNS Notice of Q3 Results
20th Oct 2014 7:00 am RNS Change of Adviser
8th Oct 2014 4:03 pm RNS US Regulatory Approval
2nd Oct 2014 7:18 am RNS Ameluz Phase III Preliminary Results
8th Sep 2014 6:21 pm RNS Director/PDMR Shareholding
4th Sep 2014 1:50 pm RNS Director/PDMR Shareholding
4th Sep 2014 7:00 am RNS Director/PDMR Shareholding
4th Sep 2014 7:00 am RNS Update Re: Biosynth AG
29th Aug 2014 7:00 am RNS Half Yearly Report
22nd Aug 2014 7:00 am RNS Notice of Results
21st Aug 2014 1:30 pm RNS FDA pre-New Drug Application meeting for Ameluz
21st Aug 2014 7:00 am RNS Filing Re: Biosynth AG
18th Aug 2014 7:00 am RNS Belixos® launched on Amazon
14th Aug 2014 7:00 am RNS Change of Trading Currency
11th Aug 2014 7:00 am RNS Ameluz® first stage approval process Israel
6th Aug 2014 7:00 am RNS First Ameluz® sales in Central Eastern Europe
27th Jun 2014 2:53 pm RNS Result of AGM
3rd Jun 2014 7:00 am RNS AIM Admission - First Day of Dealings
12
FTSE 100 Latest
Value8,275.66
Change0.00